Crossmark

The prognostic significance of topoisomerase II alpha protein in early stage luminal breast cancer

Crossref DOI link: https://doi.org/10.1186/s12885-018-4170-7

Published Online: 2018-03-27

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

An, Xin

Xu, Fei

Luo, Rongzhen

Zheng, Qiufan

Lu, Jiabin

Yang, Yanhua

Qin, Tao

Yuan, Zhongyu

Shi, Yanxia

Jiang, Wenqi

Wang, Shusen http://orcid.org/0000-0001-5721-0840
Funding

Funding for this research was provided by:

China Scholarship Council

Medical Scientific Research Foundation of Guangdong Province, China
License Information

Text and Data Mining valid from 2018-03-27
More Information

Article History

Received: 11 January 2017

Accepted: 26 February 2018

First Online: 27 March 2018

Ethics approval and consent to participate

: The study was approved by the Ethics Committee of Sun Yat-Sen University Cancer Center. (Ref: GYX 2015–002) Written informed consents were provided by all patients.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.